The European Alliance for Spinal Muscular Atrophy (SMA) Newborn Screening has set out a goal to have SMA included in all newborn screening programmes by 2025.
To explain their position and learn more about the importance of SMA screening SMA Europe have launched a whitepaper, which can be downloaded from their website or by following the link here
.
The presentations are available for educational exchange purposes only. Products mentioned in the presentations may not be available in your country. Please consult your local PerkinElmer representative to check the products availability in your country.
Talk to one of our product experts about the right solutions for you.
Explore our articles and resources section for the latest information.
Sign up for our newsletter to find out about the latest news from PerkinElmer and the industry.
